BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28197919)

  • 1. Sumoylation and Its Contribution to Cancer.
    Lee JS; Choi HJ; Baek SH
    Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SUMO pathway components as possible cancer biomarkers.
    Mattoscio D; Chiocca S
    Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the loss of SUMO pathway function on cancer cells and tumor proliferation.
    He X; Riceberg J; Pulukuri SM; Grossman S; Shinde V; Shah P; Brownell JE; Dick L; Newcomb J; Bence N
    PLoS One; 2015; 10(4):e0123882. PubMed ID: 25860128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Ubiquitination and SUMOylation in DNA Damage Response.
    Su S; Zhang Y; Liu P
    Curr Issues Mol Biol; 2020; 35():59-84. PubMed ID: 31422933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SUMOylation of ATF3 alters its transcriptional activity on regulation of TP53 gene.
    Wang CM; Brennan VC; Gutierrez NM; Wang X; Wang L; Yang WH
    J Cell Biochem; 2013 Mar; 114(3):589-98. PubMed ID: 22991139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The transcriptional activity of co-activator AIB1 is regulated by the SUMO E3 ligase PIAS1.
    Li S; Yang C; Hong Y; Bi H; Zhao F; Liu Y; Ao X; Pang P; Xing X; Chang AK; Xiao L; Zhang Y; Wu H
    Biol Cell; 2012 May; 104(5):287-96. PubMed ID: 22283414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of ubiquitin ligases in cancer.
    Qi J; Ronai ZA
    Drug Resist Updat; 2015 Nov; 23():1-11. PubMed ID: 26690337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the sumoylation system in gene expression.
    Liu B; Shuai K
    Curr Opin Cell Biol; 2008 Jun; 20(3):288-93. PubMed ID: 18468876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SUMOylation in carcinogenesis.
    Bettermann K; Benesch M; Weis S; Haybaeck J
    Cancer Lett; 2012 Mar; 316(2):113-25. PubMed ID: 22138131
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sumoylation as an Integral Mechanism in Bacterial Infection and Disease Progression.
    Srikanth CV; Verma S
    Adv Exp Med Biol; 2017; 963():389-408. PubMed ID: 28197924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO and Nucleocytoplasmic Transport.
    Ptak C; Wozniak RW
    Adv Exp Med Biol; 2017; 963():111-126. PubMed ID: 28197909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Sumoylation in Senescence.
    Scurr LL; Haferkamp S; Rizos H
    Adv Exp Med Biol; 2017; 963():215-226. PubMed ID: 28197915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction to Sumoylation.
    Wilson VG
    Adv Exp Med Biol; 2017; 963():1-12. PubMed ID: 28197903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling pathways and the regulation of SUMO modification.
    Guo B; Yang SH; Witty J; Sharrocks AD
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1414-8. PubMed ID: 18031234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CACUL1/CAC1 attenuates p53 activity through PML post-translational modification.
    Fukuda T; Kigoshi-Tansho Y; Naganuma T; Kazaana A; Okajima T; Tsuruta F; Chiba T
    Biochem Biophys Res Commun; 2017 Jan; 482(4):863-869. PubMed ID: 27889610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An unanticipated tumor-suppressive role of the SUMO pathway in the intestine unveiled by Ubc9 haploinsufficiency.
    López I; Chalatsi E; Ellenbroek SIJ; Andrieux A; Roux PF; Cerapio JP; Jouvion G; van Rheenen J; Seeler JS; Dejean A
    Oncogene; 2020 Oct; 39(43):6692-6703. PubMed ID: 32948837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between nuclear transport and ubiquitin/SUMO modifications in the regulation of cancer-related proteins.
    Rodríguez JA
    Semin Cancer Biol; 2014 Aug; 27():11-9. PubMed ID: 24704338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO: getting it on.
    Anckar J; Sistonen L
    Biochem Soc Trans; 2007 Dec; 35(Pt 6):1409-13. PubMed ID: 18031233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sumoylation in Craniofacial Disorders.
    Pauws E; Stanier P
    Adv Exp Med Biol; 2017; 963():323-335. PubMed ID: 28197921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcriptional repression activity of KyoT2 on the Notch/RBP-J pathway is regulated by PIAS1-catalyzed SUMOylation.
    Wang J; Qin H; Liang J; Zhu Y; Liang L; Zheng M; Han H
    J Mol Biol; 2007 Jun; 370(1):27-38. PubMed ID: 17509614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.